|
CN110382020A
|
|
Cell delivery system and the method for operating cell delivery system
|
|
WO2018017538A1
|
|
Msc growth predictor assays
|
|
AU2017241807A1
|
|
Medium, methods, cells and secreted factors for stem cell culture and therapy
|
|
EP3277297A1
|
|
Methods and compositions for stimulation of cell proliferation and provision of biologically active mixtures of fgf2 isoforms
|
|
KR20200068758A
|
|
Induction medium and methods for stem cell culture and therapy
|
|
US2014219976A1
|
|
Methods and compositions for treatment of retinal degeneration
|
|
US2014099291A1
|
|
Methods and compositions for treatment of retinal degeneration
|
|
CN104519891A
|
|
Methods and compositions for treatment of traumatic brain injury and for modulation of migration of neurogenic cells
|
|
CA2862309A1
|
|
Methods and compositions for modulating angiogenesis and vasculogenesis
|
|
CN103842498A
|
|
Neurogenic and gliogenic factors and assays therefor
|
|
CN103547275A
|
|
Methods and compositions for modulating peripheral immune function
|
|
KR20160027247A
|
|
Neural regenerating cells with alterations in dna methylation
|
|
WO2009073178A1
|
|
Extracellular matrix from pluripotent cells
|
|
EP2222839A2
|
|
Methods and compositions for modulating differentiation of pluripotential cells
|
|
CN101801396A
|
|
Methods and compositions for treating neural degeneration
|
|
WO2008102460A1
|
|
Transplantation of bone marrow stromal cell-induced neural stem cells for promoting fuctional recovery after spinal cord injury
|
|
EP1855700A2
|
|
Use of neuronal precursor cells for treatment of central nervous system lesions
|
|
AU2005233582A1
|
|
Cells exhibiting neuronal progenitor cell characteristics
|
|
US2006166362A1
|
|
Differentiation of bone marrow stromal cells to neural cells or skeletal muscle cells by introduction of notch gene
|
